JOA - 2026-11-06 - Journal Article
Complications After Primary Total Joint Arthroplasty in Solid Organ Transplant Recipients.
Rosenberg SI, Chang THW, Jandzinski M, Wang Z, Hardy L, Kheir MM
Topics
Key Takeaway
Solid organ transplant recipients undergoing primary TJA had an overall complication rate of 26.2%, but 5-year PJI-free survivorship remained high at 97.8% (THA) and 96.4% (TKA), with all PJI cases occurring exclusively in renal transplant recipients.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This single-institution retrospective study examined complication rates, PJI-free and mortality-free survivorship, and risk factors for complications in SOT recipients undergoing primary TJA between 2005 and 2024. Overall complication rate was 26.2%; surgical and medical complications were each 13.0% after THA and 5.9%/20.6% after TKA. On logistic regression, higher BMI (OR 0.88, p=0.02) and liver transplant history (OR 0.21, p=0.04) were associated with increased complications, while 5-year mortality-free survivorship was notably lower after TKA (74.8%) versus THA (92.0%).
Key Limitation
The retrospective single-center design with heterogeneous transplant types and immunosuppressive regimens prevents definitive causal attribution of PJI risk to renal transplant status versus confounding immunosuppression differences.
Original Abstract
BACKGROUND
The outcomes after total joint arthroplasty (TJA) for patients who have solid organ transplants (SOT) remain unclear. This study aimed to investigate: 1) overall medical and surgical complication rates, 2) survivorship-free rates from periprosthetic joint infection (PJI) and mortality specifically, and 3) risk factors for complications in SOT recipients undergoing TJA.
METHODS
A retrospective study was performed of all SOT recipients undergoing primary TJA at a single academic institution between 2005 and 2024, with a minimum one-year follow-up. Demographics, surgical characteristics, medical comorbidities, transplant type, and immunosuppressive therapy were recorded. We identified 103 TJAs (69 total hip arthroplasties [THA], 34 total knee arthroplasties [TKA]) in 89 SOT recipients who had a mean follow-up of 4.9 years. The overall complication rate was 26.2% (27 of 103). Logistic regression and Kaplan-Meier analyses were performed. An alpha level of 0.05 denoted significance.
RESULTS
The surgical and medical complication rates were 13.0 and 13.0% after THA, and 5.9 and 20.6% after TKA, respectively. After THA, five-year infection-free and mortality-free survivorships were 97.8 and 92.0%, respectively, with no difference by transplant type (P = 0.40 and P = 0.84, respectively). After TKA, five-year infection-free and mortality-free survivorships were 96.4 and 74.8%, respectively, with no difference by transplant type (P = 0.57 and P = 0.29, respectively). When controlling for confounders, body mass index (Odds Ratio [OR] 0.88, P = 0.02) and history of liver transplant (OR 0.21, P = 0.04) were associated with increased complications.
CONCLUSION
While overall complication rates were high, SOT recipients demonstrated low PJI rates following TJA when managed with multidisciplinary perioperative care. Only renal transplant recipients developed PJI, demonstrating potentially higher susceptibility in this subgroup. The mortality rates identified are concordant with literature describing general survivorship of patients after SOT and therefore appear to not be affected by undergoing TJA.